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Background
Presenilin (PS) is the catalytic subunit of g-secretase and
mutations in this protein cause familial Alzheimer’sD i s -
ease (FAD). Moreover, g-secretase has emerged as an
appealing drug target for Alzheimer’sd i s e a s e( A D )a n d
cancer due to its central role in the generation of Ab pep-
tides and the regulation of Notch signaling. g-Secretase is
composed of at least four subunits: PS, Nicastrin, Aph1
and Pen2; with a total of 19 putative transmembrane
domains.
Result
Investigation of g-secretase structure and function has
been a formidable challenge because of its nature of
intramembranal catalysis and macromolecular complex
that requires novel chemical insights. We have developed
a reconstituted system and small molecular probes that
allow us to study the regulation of g-secretase and to elu-
cidate the mechanism of PS1 FAD mutations. We have
reconstituted g-secretase using a proteoliposomes system
and provided the final proof that g-secretase activity is an
inherent property of PS. Moreover, we have demon-
strated that PS mutations directly alter a subsite of
g-secretase active site and defined the action mechanism
of g-secretase modulators.
Conclusion
Our studies provide a molecular basis of PS1 mutations
in AD pathogenesis and offer a unique approach to eluci-
date the reaction mechanism of g-secretase, with the
expectation that these efforts will lead to the develop-
ment of effective therapies for AD and other human
disorders.
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